Dose Escalation Using Hypoxia-adjusted Radiotherapy
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Radiation: DE-HyART; Radiation: Standard Arm; Drug: Cisplatin injection; Radiation: Standard fractionation (Radiation Oncology preference) Sponsors: Rajiv Gandhi Cancer Institute& Research Center, India; Varian, a Siemens Healthineers Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | India Health | Research | Skin Cancer | Squamous Cell Carcinoma